Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol

Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol

IntroductionCachexia is common in malignant mesothelioma (MM); half of patients have malnutrition and low skeletal muscle mass. Malnourished patients have worse quality of life (QoL). Weight loss is strongly associated with poor survival. Anamorelin is an oral ghrelin receptor agonist that improves...

Full description

Bibliographic Details
Main Authors: Fraser Brims, Anna Nowak, Siao Nge Hoon, Katrina Fyfe, Carolyn J Peddle-McIntyre, Felicity Hawkins, Emily Jeffery, Hui Jun Chih, Jenette Creaney
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/7/1/e000551.full

Internet

https://bmjopenrespres.bmj.com/content/7/1/e000551.full

Similar Items